The modulation of apoptosis by oncogenic viruses

Virology Journal

Volumn 10, Issue , 2013, Pages

  Fuentes González, Alma Mariana ^a   Contreras Paredes, Adriana ^a   Manzo Merino, Joaquín ^a   Lizano, Marcela ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Apoptosis; Cancer; Oncogene; Virus

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DOUBLE STRANDED DNA; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; GLYCOPROTEIN E1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B; PROCASPASE 8; PROTEIN BAK; PROTEIN E6; PROTEIN E7; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANUS CANCER; APOPTOSIS; BURKITT LYMPHOMA; CANCER MORTALITY; CANCER PATIENT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL GROWTH; EMBRYO DEVELOPMENT; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE SYSTEM; KAPOSI SARCOMA; LIVER CELL CARCINOMA; MEDIATOR; NASOPHARYNX CARCINOMA; NEOPLASM; NONHUMAN; OROPHARYNX CARCINOMA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; T CELL LYMPHOMA; TUMOR VIRUS; UTERINE CERVIX CANCER; VIRUS GENOME; VIRUS INFECTION; VIRUS LOAD; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSFORMATION; WART VIRUS;

APOPTOSIS; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; ONCOGENIC VIRUSES;

HEPATITIS C VIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS;

EID: 84878505342     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-182     Document Type: Review

References (171)

1. Viruses associated with human cancer. McLaughlin-Drubin M, Munger K, Biochim Biophys Acta 2008 1782 suppl 3 127 150
2. The Nobel prizes http://www.nobelprize.org
3. Viruses in human cancers. zur Hausen H, Science 1991 254 1167 1173 (Pubitemid 21917442)
4. A Transmissible Avian Neoplasm. (Sarcoma of the Common Fowl.). Rous P, J Exp Med 1910 12 696 705
5. Infectious Papillomatosis of Rabbits: With a Note on the Histopathology. Shope RE, Hurst EW, J Exp Med 1933 58 607 624
6. Some Possible Effects of Nursing on the Mammary Gland Tumor Incidence in Mice. Bittner JJ, Science 1936 84 162
7. "Spontaneous" leukemia developing in C3H mice following inoculation in infancy, with AK-leukemic extracts, or AK-embryos. Gross L, Proc Soc Exp Biol Med 1951 76 27 32
8. Studies with Burkitt's lymphoma. Epstein MA, Barr YM, Achong BG, Wistar Inst Symp Monogr 1965 4 69 82
9. Cancer of the cervix: a sexually transmitted infection? Beral V, Lancet 1974 1 1037 1040
10. Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus. zur Hausen H, Meinhof W, Scheiber W, Bornkamm GW, Int J Cancer 1974 13 650 656
11. The role of HPV in head and neck cancer and review of the HPV vaccine. D'Souza G, Dempsey A, Prev Med 2011 53 Suppl 1 5 S11
12. Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Vogel CL, Anthony PP, Mody N, Barker LF, Lancet 1970 2 621 624
13. Hepatitis-associated antigen and antibody in hepatocellular carcinoma: results of a continuing study. Vogel CL, Anthony PP, Sadikali F, Barker LF, Peterson MR, J Natl Cancer Inst 1972 48 1583 1588
14. Viral hepatitis: Global goals for vaccination. Lavanchy DJ, Clin Virol 2012 55 296 302
15. Both core and F proteins of hepatitis C virus could enhance cell proliferation in transgenic mice. Hu WT, Li HC, Lee SK, Ma HC, Yang CH, Chen HL, Lo SY, Biochem Biophys Res Commun 2013 435 147 152
16. Novel mechanisms of EBV-induced oncogenesis. Raab-Traub N, Curr Opin Virol 2012 2 453 458
17. Burkitt's lymphoma. Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, Harrison CJ, Israels T, Bailey S, Lancet 2012 379 1234 1244
18. Sequential monitoring of plasma EBV-DNA level in a patient with EBV-positive Hodgkin lymphoma. Uchida E, Honma R, Igarashi A, Kurata M, Imadome K, Omoto E, Miura O, Arai A, Rinsho Ketsueki 2012 53 87 91
19. Novel systemic therapeutic for nasopharyngeal carcinoma. Chan SL, Ma BB, Expert Opin Ther Targets 2012 16 Suppl 1 63 S68
20. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity. Cheng TC, Hsieh SS, Hsu WL, Chen YF, Ho HH, Sheu LF, Int J Oncol 2010 36 151 160
21. Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection. Fukumoto H, Kanno T, Hasegawa H, Katano H, Front Microbiol 2011 2 175
22. Kaposi's Sarcoma Associated Herpesvirus Entry into Target Cells. Chakraborty S, Veettil MV, Chandran B, Front Microbiol 2012 3 6
23. Papillomaviruses in human cancers. zur Hausen H, Proc Assoc Am Physicians 1999 111 581 587
24. New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas. Kostareli E, Holzinger D, Hess J, Front Oncol 2012 2 36
25. Multiple human papillomavirus-16 associated digital squamous-cell carcinomas in an immunocompetent woman with prior human papillomavirus-related genital carcinoma. Hunt R, Hwa C, Tzu J, Patel R, Tyring SK, Stein J, Dermatol Online J 2011 17 20
26. Ras signaling contributes to survival of human T-cell leukemia/lymphoma virus type 1 (HTLV-1) Tax-positive T-cells. Stoppa G, Rumiato E, Saggioro D, Apoptosis 2012 17 219 228
27. Apoptosis induced by hepatitis B virus X protein in a CCL13-HBx stable cell line. Kuo CY, Tsai JI, Chou TY, Hung MJ, Wu CC, Hsu SL, Hwang GY, Oncol Rep 2012 28 127 132
28. Cellular and molecular biology of HCV infection and hepatitis. Tang H, Grise H, Clin Sci (Lond) 2009 117 49 65
29. Apoptosis: mechanisms and relevance in cancer. Vermeulen K, Van Bockstaele DR, Berneman ZN, Ann Hematol 2005 84 627 639 (Pubitemid 41554237)
30. The morphology of apoptosis. Hacker G, Cell Tissue Res 2000 301 5 17 (Pubitemid 30459851)
31. Caspase-independent mitotic death (CIMD). Kitagawa K, Niikura Y, Cell Cycle 2008 7 1001 1005 (Pubitemid 351679832)
32. Caspases in cell survival, proliferation and differentiation. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P, Cell Death Differ 2007 14 44 55 (Pubitemid 44911893)
33. Mechanisms of apoptosis. Reed JC, Am J Pathol 2000 157 1415 1430
34. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW, Mol Cell 2002 9 423 432 (Pubitemid 34195566)
35. Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ, EMBO J 2004 23 2134 2145 (Pubitemid 38737740)
36. Caspase signaling in animal development. Kuranaga E, Dev Growth Differ 2011 53 137 148
37. IAPs: what's in a name? Srinivasula SM, Ashwell JD, Mol Cell 2008 30 123 135 (Pubitemid 351626688)
38. Caspase activation, inhibition, and reactivation: a mechanistic view. Shi Y, Protein Sci 2004 13 1979 1987 (Pubitemid 38989605)
39. IAPs, RINGs and ubiquitylation. Vaux DL, Silke J, Nat Rev Mol Cell Biol 2005 6 287 297 (Pubitemid 40516895)
40. Future trends for treatment of APS. Lockshin MD, J Autoimmun 2000 15 261 264
41. Survivin expression and targeting in breast cancer. Jha K, Shukla M, Pandey M, Surg Oncol 2012 21 125 131
42. Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Bandala E, Espinosa M, Maldonado V, Melendez-Zajgla J, Biochem Pharmacol 2001 62 13 19 (Pubitemid 32488973)
43. Papillomavirus infections:a major cause of human cancers. zur Hausen H, Biochim Biophys Acta 1996 1288 55 F78
44. HPV-related carcinogenesis: basic concepts, viral types and variants. Lizano M, Berumen J, Garcia-Carranca A, Arch Med Res 2009 40 428 434
45. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL, JAMA 2001 286 3106 3114 (Pubitemid 34016525)
46. The natural history of cervical HPV infection: unresolved issues. Woodman CB, Collins SI, Young LS, Nat Rev Cancer 2007 7 11 22 (Pubitemid 46020844)
47. Human papillomavirus and cervical cancer. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, Lancet 2007 370 890 907 (Pubitemid 47371147)
48. Association of human papillomavirus type 16 long control region mutation and cervical cancer. Pientong C, Wongwarissara P, Ekalaksananan T, Swangphon P, Kleebkaow P, Kongyingyoes B, Siriaunkgul S, Tungsinmunkong K, Suthipintawong C, Virol J 2013 10 30 37
49. Modulation of apoptosis by early human papillomavirus proteins in cervical cancer. Lagunas-Martinez A, Madrid-Marina V, Gariglio P, Biochim Biophys Acta 2010 1805 6 16
50. Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. Garnett TO, Duerksen-Hughes PJ, Arch Virol 2006 151 2321 2335 (Pubitemid 44819331)
51. HPV + cervical carcinomas and cell lines display altered expression of caspases. Arechaga-Ocampo E, Pereira-Suarez AL, del Moral-Hernandez O, Cedillo-Barron L, Rodriguez-Sastre MA, Castillo-Alvarez A, Lopez-Bayghen E, Villegas-Sepulveda N, Gynecol Oncol 2008 108 10 18 (Pubitemid 350299418)
52. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Zacny VL, Oncogene 2001 20 7888 7898 (Pubitemid 33135315)
53. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Howes KA, Ransom N, Papermaster DS, Lasudry JG, Albert DM, Windle JJ, Genes Dev 1994 8 1300 1310 (Pubitemid 24181321)
54. The HPV-16 E7 oncogene sensitizes malignant cells to IFN-alpha-induced apoptosis. Thyrell L, Sangfelt O, Zhivotovsky B, Pokrovskaja K, Wang Y, Einhorn S, Grander D, J Interferon Cytokine Res 2005 25 63 72 (Pubitemid 40250348)
55. Simultaneous human papilloma virus type 16 E7 and cdk inhibitor p21 expression induces apoptosis and cathepsin B activation. Kaznelson DW, Bruun S, Monrad A, Gjerlov S, Birk J, Ropke C, Norrild B, Virology 2004 320 301 312 (Pubitemid 38315156)
56. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis. Stoppler H, Stoppler MC, Johnson E, Simbulan-Rosenthal CM, Smulson ME, Iyer S, Rosenthal DS, Schlegel R, Oncogene 1998 17 1207 1214 (Pubitemid 28446160)
57. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Yuan H, Fu F, Zhuo J, Wang W, Nishitani J, An DS, Chen IS, Liu X, Oncogene 2005 24 5069 5078 (Pubitemid 41129084)
58. The HPV E7 oncoprotein inhibits tumor necrosis factor alpha-mediated apoptosis in normal human fibroblasts. Thompson DA, Zacny V, Belinsky GS, Classon M, Jones DL, Schlegel R, Munger K, Oncogene 2001 20 3629 3640 (Pubitemid 32624955)
59. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM, Cell 1990 63 1129 1136 (Pubitemid 120035062)
60. Inhibition of Bak-induced apoptosis by HPV-18 E6. Thomas M, Banks L, Oncogene 1998 17 2943 2954 (Pubitemid 29012197)
61. The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis. Filippova M, Parkhurst L, Duerksen-Hughes PJ, J Biol Chem 2004 279 25729 25744 (Pubitemid 38756837)
62. Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis. Garnett TO, Filippova M, Duerksen-Hughes PJ, Cell Death Differ 2006 13 1915 1926 (Pubitemid 44542404)
63. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Gross-Mesilaty S, Reinstein E, Bercovich B, Tobias KE, Schwartz AL, Kahana C, Ciechanover A, Proc Natl Acad Sci USA 1998 95 8058 8063 (Pubitemid 28326065)
64. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA, J Virol 2008 82 10408 10417 (Pubitemid 352691188)
65. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. Kabsch K, Alonso A, J Virol 2002 76 12162 12172 (Pubitemid 35304314)
66. The human papillomavirus type 16 E5 protein modulates ERK1/2 and p38 MAP kinase activation by an EGFR-independent process in stressed human keratinocytes. Crusius K, Rodriguez I, Alonso A, Virus Genes 2000 20 65 69 (Pubitemid 30168919)
67. Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Moody CA, Fradet-Turcotte A, Archambault J, Laimins LA, Proc Natl Acad Sci USA 2007 104 19541 19546
68. The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic. Blachon S, Demeret C, Biochimie 2003 85 813 819 (Pubitemid 37383800)
69. Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. Frattini MG, Hurst SD, Lim HB, Swaminathan S, Laimins LA, EMBO J 1997 16 318 331 (Pubitemid 27049389)
70. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. Desaintes C, Demeret C, Goyat S, Yaniv M, Thierry F, EMBO J 1997 16 504 514 (Pubitemid 27067780)
71. Direct activation of caspase 8 by the proapoptotic E2 protein of HPV18 independent of adaptor proteins. Thierry F, Demeret C, Cell Death Differ 2008 15 1356 1363
72. Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP. Wang W, Fang Y, Sima N, Li Y, Li W, Li L, Han L, Liao S, Han Z, Gao Q, et al. Apoptosis 2011 16 55 66
73. Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. Bellanger S, Tan CL, Xue YZ, Teissier S, Thierry F, Am J Cancer Res 2011 1 373 389
74. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells. Desaintes C, Goyat S, Garbay S, Yaniv M, Thierry F, Oncogene 1999 18 4538 4545 (Pubitemid 29405885)
75. Global cancer statistics in the year 2000. Parkin DM, Lancet Oncol 2001 2 533 543 (Pubitemid 33586866)
76. Prevalence of hepatitis C virus in the Mexican population: a systematic review. Santos-Lopez G, Sosa-Jurado F, Vallejo-Ruiz V, Melendez-Mena D, Reyes-Leyva J, J Infect 2008 56 281 290
77. Epidemiology and clinical manifestations of viral hepatitis. Aguilera Guirao A, Romero Yuste S, Regueiro BJ, Enferm Infecc Microbiol Clin 2006 24 264 276 (Pubitemid 43874423)
78. Primary liver cancer: worldwide incidence and trends. Bosch FX, Ribes J, Diaz M, Cleries R, Gastroenterology 2004 127 1 5 S16
79. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma. Kew MC, Pathol Biol 2010 58 273 277
80. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, et al. Hepatology 2005 42 962 973 (Pubitemid 41401136)
81. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W, Nat Med 2009 15 31 33
82. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. Lin C, Lindenbach BD, Pragai BM, McCourt DW, Rice CM, J Virol 1994 68 5063 5073 (Pubitemid 24226574)
83. Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways. Hassan M, Selimovic D, Ghozlan H, Abdel-kader O, Hepatology 2009 49 1469 1482
84. Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody. Cocquerel L, Quinn ER, Flint M, Hadlock KG, Foung SK, Levy S, J Virol 2003 77 1604 1609 (Pubitemid 36055582)
85. Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. Steinmann E, Penin F, Kallis S, Patel AH, Bartenschlager R, Pietschmann T, PLoS Pathog 2007 3 103
86. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. Kolykhalov AA, Mihalik K, Feinstone SM, Rice CM, J Virol 2000 74 2046 2051 (Pubitemid 30434065)
87. Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase. Lam AM, Frick DN, J Virol 2006 80 404 411
88. Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B. Koch JO, Bartenschlager R, J Virol 1999 73 7138 7146 (Pubitemid 29383194)
89. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. Egger D, Wolk B, Gosert R, Bianchi L, Blum HE, Moradpour D, Bienz K, J Virol 2002 76 5974 5984 (Pubitemid 34556292)
90. Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Evans MJ, Rice CM, Goff SP, Proc Natl Acad Sci USA 2004 101 13038 13043 (Pubitemid 39167579)
91. Mechanism of de novo initiation by the hepatitis C virus RNA-dependent RNA polymerase: role of divalent metals. Ranjith-Kumar CT, Kim YC, Gutshall L, Silverman C, Khandekar S, Sarisky RT, Kao CC, J Virol 2002 76 12513 12525 (Pubitemid 35386937)
92. Hepatitis C virus infection and apoptosis. Fischer R, Baumert T, Blum HE, World J Gastroenterol 2007 13 4865 4872 (Pubitemid 47496752)
93. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR, Barber GN, J Virol 2000 74 1513 1523 (Pubitemid 30044102)
94. TRAIL: a multifunctional cytokine. Schaefer U, Voloshanenko O, Willen D, Walczak H, Front Biosci 2007 12 3813 3824
95. Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells. Fischer R, Schmitt M, Bode JG, Haussinger D, Gastroenterology 2001 120 1212 1226 (Pubitemid 32246675)
96. Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins. Machida K, Tsukiyama-Kohara K, Seike E, Tone S, Shibasaki F, Shimizu M, Takahashi H, Hayashi Y, Funata N, Taya C, et al. J Biol Chem 2001 276 12140 12146
97. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Ruggieri A, Harada T, Matsuura Y, Miyamura T, Virology 1997 229 68 76 (Pubitemid 27243489)
98. Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. Saito K, Meyer K, Warner R, Basu A, Ray RB, Ray R, J Virol 2006 80 4372 4379
99. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. Otsuka M, Kato N, Lan K, Yoshida H, Kato J, Goto T, Shiratori Y, Omata M, J Biol Chem 2000 275 34122 34130
100. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, Lai MM, J Virol 2006 80 7199 7207 (Pubitemid 44025216)
101. Structural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1alpha and PKR. Sudha G, Yamunadevi S, Tyagi N, Das S, Srinivasan N, BMC Struct Biol 2012 12 28
102. Inhibition of Cytochrome c Release in Fas-mediated Signaling Pathway in Transgenic Mice Induced to Express Hepatitis C. Machida K, Tsukiyama-Kohara K, Seike E, Tone S, Shibasaki F, Shimizu M, Takahashi H, Hayashi Y, Funata N, Taya C, Yonekawa H, Kohara M, J Bol Chem 2001 276 12140 12146
103. Expression of HCV E1 protein in baculovirus-infected cells: effects on cell viability and apoptosis induction. Ciccaglione AR, Marcantonio C, Costantino A, Equestre M, Rapicetta M, Intervirology 2003 46 121 126 (Pubitemid 36407929)
104. The transmembrane domain of hepatitis C virus E1 glycoprotein induces cell death. Ciccaglione AR, Marcantonio C, Tritarelli E, Equestre M, Magurano F, Costantino A, Nicoletti L, Rapicetta M, Virus Res 2004 104 1 9 (Pubitemid 38721258)
105. The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. Erdtmann L, Franck N, Lerat H, Le Seyec J, Gilot D, Cannie I, Gripon P, Hibner U, Guguen-Guillouzo C, J Biol Chem 2003 278 18256 18264 (Pubitemid 36799444)
106. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J, Nature 2005 437 1167 1172 (Pubitemid 41509355)
107. Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis. Nomura-Takigawa Y, Nagano-Fujii M, Deng L, Kitazawa S, Ishido S, Sada K, Hotta H, J Gen Virol 2006 87 1935 1945 (Pubitemid 43985876)
108. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Chung YL, Sheu ML, Yen SH, Int J Cancer 2003 107 65 73
109. Human T-cell leukemia virus type I and adult T-cell leukemia. Matsuoka M, Oncogene 2003 22 5131 5140 (Pubitemid 37059594)
110. Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Nicot C, Harrod RL, Ciminale V, Franchini G, Oncogene 2005 24 6026 6034 (Pubitemid 43086120)
111. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM, J Virol 2002 76 12813 12822 (Pubitemid 35386965)
112. Activation of LTRs from different human endogenous retrovirus (HERV) families by the HTLV-1 tax protein and T-cell activators. Toufaily C, Landry S, Leib-Mosch C, Rassart E, Barbeau B, Viruses 2011 3 2146 2159
113. Human T-cell leukemia virus type I tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T-cells through nuclear factor-kappaB and c-AMP responsive element binding protein pathways. Mori N, Fujii M, Cheng G, Ikeda S, Yamasaki Y, Yamada Y, Tomonaga M, Yamamoto N, Virus Genes 2001 22 279 287 (Pubitemid 32587634)
114. Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Waldele K, Silbermann K, Schneider G, Ruckes T, Cullen BR, Grassmann R, Blood 2006 107 4491 4499 (Pubitemid 43801377)
115. In vitro activation of the IkappaB kinase complex by human T-cell leukemia virus type-1 Tax. Mukherjee S, Negi VS, Keitany G, Tanaka Y, Orth K, J Biol Chem 2008 283 15127 15133
116. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. Xiao G, Cvijic ME, Fong A, Harhaj EW, Uhlik MT, Waterfield M, Sun SC, EMBO J 2001 20 6805 6815 (Pubitemid 33134210)
117. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription. Suzuki T, Hirai H, Yoshida M, Oncogene 1994 9 3099 3105 (Pubitemid 24338436)
118. The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. Bex F, McDowall A, Burny A, Gaynor R, J Virol 1997 71 3484 3497 (Pubitemid 27172359)
119. Transcriptional activator Tax of HTLV-1 binds to the NF-kappa B precursor p105. Hirai H, Fujisawa J, Suzuki T, Ueda K, Muramatsu M, Tsuboi A, Arai N, Yoshida M, Oncogene 1992 7 1737 1742
120. Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN, Oncogene 2005 24 6719 6728 (Pubitemid 41486802)
121. Human T-cell leukemia virus type 1 tax dysregulates beta-catenin signaling. Tomita M, Kikuchi A, Akiyama T, Tanaka Y, Mori N, J Virol 2006 80 10497 10505 (Pubitemid 44628896)
122. Control of cell death pathways by HTLV-1 proteins. Saggioro D, Silic-Benussi M, Biasiotto R, D'Agostino DM, Ciminale V, Front Biosci 2009 14 3338 3351
123. A Second Virus-Carrying Tissue Culture Strain (Eb2) of Lymphoblasts from Burkitt's Lymphoma. Epstein MA, Barr YM, Achong BG, Pathol Biol (Paris) 1964 12 1233 1234
124. Spectrum of Epstein-Barr virus-associated diseases. Kutok JL, Wang F, Annu Rev Pathol 2006 1 375 404
125. DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA. Given D, Yee D, Griem K, Kieff E, J Virol 1979 30 852 862 (Pubitemid 9194328)
126. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR, PLoS Pathog 2006 2 Suppl 3 23
127. Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter? van den Bosch CA, Lancet Oncol 2004 5 738 746
128. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. Polack A, Hortnagel K, Pajic A, Christoph B, Baier B, Falk M, Mautner J, Geltinger C, Bornkamm GW, Kempkes B, Proc Natl Acad Sci USA 1996 93 10411 10416
129. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Kennedy G, Komano J, Sugden B, Proc Natl Acad Sci USA 2003 100 14269 14274 (Pubitemid 37499226)
130. Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs. Yamamoto N, Takizawa T, Iwanaga Y, Shimizu N, Yamamoto N, FEBS Lett 2000 484 153 158
131. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K, EMBO J 2002 21 954 965 (Pubitemid 34206168)
132. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG, Proc Natl Acad Sci USA 1993 90 232 236 (Pubitemid 23010284)
133. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. Komano J, Maruo S, Kurozumi K, Oda T, Takada K, J Virol 1999 73 9827 9831
134. Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo. Panagopoulos D, Victoratos P, Alexiou M, Kollias G, Mosialos G, J Virol 2004 78 13253 13261 (Pubitemid 39507830)
135. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E, Cell 1995 80 389 399
136. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. Eliopoulos AG, Caamano JH, Flavell J, Reynolds GM, Murray PG, Poyet JL, Young LS, Oncogene 2003 22 7557 7569 (Pubitemid 37464088)
137. Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. Nguyen HQ, Magaret AS, Kitahata MM, Van Rompaey SE, Wald A, Casper C, AIDS 2008 22 937 945 (Pubitemid 351652244)
138. Kaposi's sarcoma and its associated Herpesvirus. Mesri EA, Cesarman E, Boshoff C, Nat Rev Cancer 2010 10 707 719
139. Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Lebbe C, Porcher R, Marcelin AG, Agbalika F, Dussaix E, Samuel D, Varnous S, Euvrard S, Bigorie A, Creusvaux H, Legendre C, Frances C, Am J Transplant 2013 13 207 213
140. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C, Blood 2000 100 3415 3418
141. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Wu W, Vieira J, Fiore N, Banerjee P, Sieburg M, Rochford R, Harrington W Jr, Feuer G, Blood 2006 108 141 151 (Pubitemid 43990622)
142. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. Sharma-Walia N, Paul AG, Bottero V, Sadagopan S, Veettil MV, Kerur N, Chandran B, LoS Pathog 2010 6 1000777
143. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. Renne R, Lagunoff M, Zhong W, Ganem D, J Virol 1996 70 8151 8154 (Pubitemid 26339129)
144. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Lagunoff M, Ganem D, Virology 1997 236 147 154 (Pubitemid 27410362)
145. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS, Proc Natl Acad Sci USA 1996 93 14862 14867 (Pubitemid 26419060)
146. Kaposi's sarcoma-associated herpes virus expresses an array of viral microRNA latently infected cells. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR, Proc Natl Acad Sci USA 2005 102 5570 5575 (Pubitemid 40530298)
147. KSHV infection and the pathogenesis of Kaposi's sarcoma. Ganem D, Annu Rev Pathol 2006 1 273 296
148. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Radkov SA, Kellam P, Boshoff C, Nature Med 2000 6 1121 1127
149. A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcomaassociated herpesvirus latency. Fujimuro M, Wu FY, ApRhys C, Kajumbula H, Young DB, Hayward GS, Hayward SD, Nature Med 2003 9 300 306 (Pubitemid 36362785)
150. KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Di Bartolo DL, Cannon M, Liu YF, Renne R, Chadburn A, Boshoff C, Cesarman E, Blood 2008 111 4731 4740
151. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. McCormick C, Ganem D, Science 2005 307 739 741 (Pubitemid 40194646)
152. Kaposi's Sarcoma-Associated Herpesvirus vCyclin Open Reading Frame Contains an Internal Ribosome. Bieleski L, Talbot SJ, J Virol 2001 75 1864 1869 (Pubitemid 32110176)
153. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Ojala PM, Ojala PM, Yamamoto K, Castaños-Vélez E, Biberfeld P, Korsmeyer SJ, Mäkelä TP, Nature Cell Biol. 2000 2 819 825
154. Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome. Bagnéris C, Ageichik AV, Cronin N, Wallace B, Collins M, Boshoff C, Waksman G, Barrett T, Mol Cell 2008 30 620 623
155. A Virally Encoded Small Peptide Regulates RTA Stability and Facilitates Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication. Jaber T, Yuan Y, J Virol 2013 87 3461 3470
156. The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. Chandriani S, Xu Y, Ganem D, J Virol 2010 84 7934 7942
157. Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. Song MJ, Deng H, Sun R, J Virol 2003 77 9451 9462 (Pubitemid 37011041)
158. Kaposi's Sarcoma Associated Herpesvirus K3 and K5 Proteins Down Regulate Both DC-SIGN and DC-SIGNR. Lang SM, Bynoe MO, Karki R, Tartell MA, Means RE, PLoS One 2013 8 58056
159. HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK- 3β signaling pathway. Zhou F, Xue M, Qin D, Zhu X, Wang C, Zhu J, Hao T, Cheng L, Chen X, Bai Z, Feng N, Gao SJ, Lu C, PLoS One 2013 8 53145
160. Bim nuclear translocation and inactivation by viral interferon regulatory factor. Young Bong C, John N, PLoS Pathog 2010 5 6 e1001031
161. The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor. Lüttichau HR,
162. Autocrine and Paracrine Promotion of Cell Survival and Virus Replication by Human Herpesvirus 8 Chemokines. Young Bong C, John N, J Virol 2008 83 6501 6513
163. Latent and lytic HHV-8 mRNA expression in PBMCs and Kaposi's sarcoma skin biopsies of AIDS Kaposi's sarcoma patients. Polstra AM, Goudsmit J, Cornelissen M, J Med Virol 2003 70 624 627 (Pubitemid 36734729)
164. KSHV manipulation of the cell cycle and apoptosis. Moore PS, Human Herpesviruses. Biology, Therapy, and Immunoprophylaxis Cambridge: Cambridge University Press, Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, 2007 Chapter 30
165. Identification of cellular genes targeted by KSHV-encoded microRNAs. Samols MA, Skalsky RL, Mal-donado AM, Riva A, Lopez MC, Baker HV, Renne R, PLoSPathog 2007 3 65
166. Regulation of herpesvirus lifecycle by viral microRNAs. Lei X, Bai Z, Ye F, Huang Y, Gao SJ, Virulence 2010 1 433 435
167. Tandem array based expression screens identify host mRNA targets of virus encoded microRNAs. Ziegelbauer JM, Sullivan CS, Ganem D, Nat Genet 2009 41 130 134
168. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. Kang H, Wiedmer A, Yuan Y, Robertson E, Lieberman PM, PLoS Pathog 2011 7 1002140
169. BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2. Flanagan AM, Letai A, Cell Death Differ 2008 15 580 588 (Pubitemid 351267308)
170. Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. Shin YC, Nakamura H, Liang X, Feng P, Chang H, Kowalk TF, Jung JU, J Virol 2006 80 2257 2266 (Pubitemid 43271532)
171. The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. Tomlinson CC, Damania B, J Virol 2008 78 1918 1927